AMBER RIECKEN: Open Payments
NPI 1508449893 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 36 payments from 15 companies in 2025. Trend: 2023 $1,513 · 2024 $2,498 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 4 | $116 |
| ABBVIE INC. | 4 | $92 |
| Janssen Biotech, Inc. | 5 | $84 |
| 180 Medical, Inc. | 3 | $73 |
| Merck Sharp & Dohme LLC | 4 | $67 |
| UROGEN PHARMA, INC. | 3 | $66 |
| Boston Scientific Corporation | 3 | $62 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| TOLMAR, INC. | 2 | $38 |
| Teleflex LLC | 1 | $25 |
Products named: ADSTILADRIN, ERLEADA, LUPRON DEPOT, KEYTRUDA, SpaceOAR VUE System - 10mL, GENTLECATH, ELIGARD, Xtandi.
Industry payments across NE — which companies pay providers there.
